Literature DB >> 17645242

A sporadic case of Creutzfeldt-Jakob disease with beta-amyloid deposits and alpha-synuclein inclusions.

Anne Vital1, Marie-Hélène Canron, Roger Gil, Jean-Jacques Hauw, Claude Vital.   

Abstract

Neurodegenerative disorders are characterized by the correlation of clinical symptoms and neuropathological changes in the brain. However, overlaps between distinct entities are becoming more and more evident. We report the coexistence of Alzheimer pathology and alpha-synuclein inclusions in a sporadic, methioninelvaline type 1, Creutzfeldt-Jakob disease (CJD) case. There were neurofibrillary changes in the neocortex and beta amyloid cerebral angiopathy was marked. Several Lewy bodies were present in the substantia nigra, locus ceruleus and the dorsal motor nucleus of the vagus, and alpha-synuclein cytoplasmic inclusions were also found in cortical neurons. These findings raise the debated relationship between Parkinson's disease with dementia, dementia with Lewy bodies and a Lewy body variant of Alzheimer disease. Among the factors that may have contributed to this considerable morphological overlap are the patient's age (79 years at autopsy) and the over 2-year duration of the disease. As the average disease duration in sporadic methionine/valine type 1 CJD is less than 6 months, it seems legitimate to speculate that the initial symptoms resulted from Alzheimer and alpha-synuclein related pathologies. This observation shows that CJD can be present in elderly patients who are suspected of having other neurodegenerative diseases, which could underline the importance of neuropathology-based surveillance systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645242     DOI: 10.1111/j.1440-1789.2007.00755.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  8 in total

1.  Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype.

Authors:  Suman Jayadev; David Nochlin; Parvoneh Poorkaj; Ellen J Steinbart; James A Mastrianni; Thomas J Montine; Bernardino Ghetti; Gerard D Schellenberg; Thomas D Bird; James B Leverenz
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

2.  Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype.

Authors:  Nupur Ghoshal; Ignazio Cali; Richard Justin Perrin; S Andrew Josephson; Ning Sun; Pierluigi Gambetti; John Carl Morris
Journal:  Arch Neurol       Date:  2009-10

3.  Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils.

Authors:  Shailendra Dhakal; Courtney E Wyant; Hannah E George; Sarah E Morgan; Vijayaraghavan Rangachari
Journal:  J Mol Biol       Date:  2021-03-24       Impact factor: 5.469

4.  Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study.

Authors:  Ignazio Cali; Mark L Cohen; Stephane Haik; Piero Parchi; Giorgio Giaccone; Steven J Collins; Diane Kofskey; Han Wang; Catriona A McLean; Jean-Philippe Brandel; Nicolas Privat; Véronique Sazdovitch; Charles Duyckaerts; Tetsuyuki Kitamoto; Ermias D Belay; Ryan A Maddox; Fabrizio Tagliavini; Maurizio Pocchiari; Ellen Leschek; Brian S Appleby; Jiri G Safar; Lawrence B Schonberger; Pierluigi Gambetti
Journal:  Acta Neuropathol Commun       Date:  2018-01-08       Impact factor: 7.801

5.  Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.

Authors:  Elizaveta Katorcha; Natallia Makarava; Young Jin Lee; Iris Lindberg; Mervyn J Monteiro; Gabor G Kovacs; Ilia V Baskakov
Journal:  PLoS Pathog       Date:  2017-08-10       Impact factor: 6.823

6.  Parkinson's disease with a typical clinical course of 17 years overlapped by Creutzfeldt-Jakob disease: an autopsy case report.

Authors:  Shin-Ichiro Kubo; Tomoyasu Matsubara; Takeshi Taguchi; Renpei Sengoku; Atsuko Takeuchi; Yuko Saito
Journal:  BMC Neurol       Date:  2021-12-10       Impact factor: 2.474

7.  α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication.

Authors:  Suzana Aulić; Lara Masperone; Joanna Narkiewicz; Elisa Isopi; Edoardo Bistaffa; Elena Ambrosetti; Beatrice Pastore; Elena De Cecco; Denis Scaini; Paola Zago; Fabio Moda; Fabrizio Tagliavini; Giuseppe Legname
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

8.  Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.

Authors:  Makoto Hashimoto; Gilbert Ho; Yoshiki Takamatsu; Ryoko Wada; Shuei Sugama; Masaaki Waragai; Eliezer Masliah; Takato Takenouchi
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.